Connection

Jacqueline Mcginty to Dynorphins

Back to Details
This is a "connection" page, showing publications Jacqueline Mcginty has written about Dynorphins.
Jacqueline Mcginty
Connection Strength
2.836
Dynorphins
  1. Opioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injury. Neuroscience. 2000; 99(1):189-97.
    View in: PubMed
    Score: 0.162
  2. The muscarinic toxin 3 augments neuropeptide mRNA in rat striatum in vivo. Eur J Pharmacol. 1997 Sep 03; 334(1):43-7.
    View in: PubMed
    Score: 0.138
  3. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Neuroscience. 1996 Nov; 75(1):43-56.
    View in: PubMed
    Score: 0.130
  4. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse. 1996 Feb; 22(2):114-22.
    View in: PubMed
    Score: 0.123
  5. The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Brain Res Mol Brain Res. 1996 Jan; 35(1-2):237-48.
    View in: PubMed
    Score: 0.123
  6. Acute methamphetamine-induced zif/268, preprodynorphin, and preproenkephalin mRNA expression in rat striatum depends on activation of NMDA and kainate/AMPA receptors. Brain Res Bull. 1996; 39(6):349-57.
    View in: PubMed
    Score: 0.123
  7. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain. Neuroscience. 1995 Sep; 68(1):83-95.
    View in: PubMed
    Score: 0.120
  8. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain. J Pharmacol Exp Ther. 1995 May; 273(2):909-17.
    View in: PubMed
    Score: 0.117
  9. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Brain Res Mol Brain Res. 1995 Apr; 29(2):201-10.
    View in: PubMed
    Score: 0.116
  10. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 1995 Mar 06; 673(2):262-74.
    View in: PubMed
    Score: 0.116
  11. Forskolin induces preproenkephalin and preprodynorphin mRNA in rat striatum as demonstrated by in situ hybridization histochemistry. Synapse. 1995 Mar; 19(3):151-9.
    View in: PubMed
    Score: 0.116
  12. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse. 1994 Dec; 18(4):343-53.
    View in: PubMed
    Score: 0.114
  13. Role of kainate/AMPA receptors in induction of striatal zif/268 and preprodynorphin mRNA by a single injection of amphetamine. Brain Res Mol Brain Res. 1994 Nov; 27(1):118-26.
    View in: PubMed
    Score: 0.113
  14. A deficit in preprodynorphin mRNA expression in hippocampus of spontaneously hypertensive rats. Brain Res Mol Brain Res. 1994 Jun; 23(4):345-8.
    View in: PubMed
    Score: 0.110
  15. Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Brain Res Mol Brain Res. 1994 Feb; 21(3-4):359-62.
    View in: PubMed
    Score: 0.107
  16. Convulsant doses of cocaine alter immediate early gene and opioid peptide expression in rat limbic forebrain. Brain Res Mol Brain Res. 1993 Nov; 20(3):285-8.
    View in: PubMed
    Score: 0.106
  17. Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. Neuroreport. 1993 May; 4(5):543-6.
    View in: PubMed
    Score: 0.102
  18. Amphetamine-induced locomotion and gene expression are altered in BDNF heterozygous mice. Genes Brain Behav. 2008 Nov; 7(8):906-14.
    View in: PubMed
    Score: 0.073
  19. Amygdaloid kindling increases enkephalin-like immunoreactivity but decreases dynorphin-A-like immunoreactivity in rat hippocampus. Neurosci Lett. 1986 Oct 30; 71(1):31-6.
    View in: PubMed
    Score: 0.065
  20. Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuroscience. 2006; 138(4):1289-98.
    View in: PubMed
    Score: 0.062
  21. NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Brain Res. 2002 Mar 22; 931(1):41-9.
    View in: PubMed
    Score: 0.047
  22. Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury. Pain. 2001 Feb 01; 90(1-2):181-90.
    View in: PubMed
    Score: 0.044
  23. Intrastriatal GABA(A) receptor blockade does not alter dopamine D(1)/D(2) receptor interactions in the intact rat striatum. Neuroscience. 2001; 102(2):381-9.
    View in: PubMed
    Score: 0.043
  24. Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum. Brain Res Mol Brain Res. 1998 Mar 01; 54(2):262-9.
    View in: PubMed
    Score: 0.036
  25. Drugs of abuse and striatal gene expression. Adv Pharmacol. 1998; 42:1017-9.
    View in: PubMed
    Score: 0.035
  26. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats. Brain Res. 1997 Feb 14; 748(1-2):62-70.
    View in: PubMed
    Score: 0.033
  27. Short-term cocaine self administration alters striatal gene expression. Brain Res Bull. 1995; 37(5):523-7.
    View in: PubMed
    Score: 0.029
  28. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse. 1994 Sep; 18(1):35-45.
    View in: PubMed
    Score: 0.028
  29. Kainic acid depresses the ex vivo release of dynorphin B and glutamate from rat hippocampal mossy fiber synaptosomes. Neurosci Lett. 1992 Mar 30; 137(2):149-53.
    View in: PubMed
    Score: 0.024
  30. A glutamate antagonist blocks perforant path stimulation-induced reduction of dynorphin peptide and prodynorphin mRNA levels in rat hippocampus. Brain Res. 1991 Oct 25; 562(2):243-50.
    View in: PubMed
    Score: 0.023
  31. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci. 1991 Apr; 11(4):1016-31.
    View in: PubMed
    Score: 0.022
  32. High density of zinc-containing and dynorphin B- and substance P-immunoreactive terminals in the marginal division of the rat striatum. Brain Res Bull. 1990 Feb; 24(2):201-5.
    View in: PubMed
    Score: 0.020
  33. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res. 1990 Jan 15; 507(1):57-64.
    View in: PubMed
    Score: 0.020
  34. Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J Pharmacol Exp Ther. 1988 Jul; 246(1):403-8.
    View in: PubMed
    Score: 0.018
  35. Lithium increases dynorphin A(1-8) and prodynorphin mRNA levels in the basal ganglia of rats. Brain Res. 1988 Apr; 427(2):155-63.
    View in: PubMed
    Score: 0.018
  36. Kainic acid as a tool to study the regulation and function of opioid peptides in the hippocampus. Toxicology. 1987 Oct 30; 46(2):141-57.
    View in: PubMed
    Score: 0.017
  37. Increased enkephalin and dynorphin immunoreactivity in the hippocampus of seizure sensitive Mongolian gerbils. Brain Res. 1987 Jan 20; 401(2):353-8.
    View in: PubMed
    Score: 0.016
  38. Kainic acid alters the metabolism of Met5-enkephalin and the level of dynorphin A in the rat hippocampus. J Neurosci. 1986 Oct; 6(10):3094-102.
    View in: PubMed
    Score: 0.016
  39. Dynorphin- and enkephalin-like immunoreactivity is altered in limbic-basal ganglia regions of rat brain after repeated electroconvulsive shock. J Neurosci. 1986 Mar; 6(3):644-9.
    View in: PubMed
    Score: 0.016
  40. A subset of beta-endorphin- or dynorphin-containing neurons in the medial basal hypothalamus accumulates estradiol. Neuroendocrinology. 1985 Nov; 41(5):417-26.
    View in: PubMed
    Score: 0.015
  41. Repeated electroconvulsive shocks alter the biosynthesis of enkephalin and concentration of dynorphin in the rat brain. Neuropeptides. 1985 Feb; 5(4-6):557-60.
    View in: PubMed
    Score: 0.014
  42. The distribution and morphology of opioid peptide immunoreactive neurons in the cerebral cortex of rats. J Neurosci. 1984 Apr; 4(4):1104-17.
    View in: PubMed
    Score: 0.014
  43. Double immunostaining reveals distinctions among opioid peptidergic neurons in the medial basal hypothalamus. Brain Res. 1983 Nov 14; 278(1-2):145-53.
    View in: PubMed
    Score: 0.013
  44. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc Natl Acad Sci U S A. 1983 Jan; 80(2):589-93.
    View in: PubMed
    Score: 0.012
  45. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury. Neuroscience. 2001; 104(3):863-74.
    View in: PubMed
    Score: 0.011
  46. Dentate granule cells are essential for kainic acid-induced wet dog shakes but not for seizures. J Neurosci. 1988 Jan; 8(1):256-64.
    View in: PubMed
    Score: 0.004
  47. Seizure-induced alterations in the metabolism of hippocampal opioid peptides suggest opioid modulation of seizure-related behaviors. NIDA Res Monogr. 1988; 82:48-66.
    View in: PubMed
    Score: 0.004
  48. Neuropeptides and the epilepsies: current perspectives. Prog Clin Biol Res. 1983; 124:105-20.
    View in: PubMed
    Score: 0.003
  49. Opioid peptides in the hippocampus: anatomical and physiological considerations. Ann N Y Acad Sci. 1982; 398:207-20.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.